Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)
Clinical trial NCT05974267 · COMPLETED
Trial details
- NCT number
- NCT05974267
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-28
- Primary completion
- 2024-12-29
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.